术前肺功能与肺癌术后患者报告结局相关
本研究在单中心对123例接受微创肺癌切除术的患者,于术前、术后1个月和6个月用PROMIS工具调查身体功能和疼痛强度,采用线性混合效应模型分析临床变量与PRO评分的关联。结果显示,术前DLCO较低与术后6个月身体功能更差(P < .01)和疼痛强度更高(P < .01)显著相关,而术后1个月无差异;其他临床因素与PRO评分无显著关联。
要点
- 术前DLCO较低与微创肺癌术后6个月身体功能更差和疼痛更重相关。
- 术前DLCO与术后1个月PRO评分无显著关联。
- DLCO可能有助于识别术后生活质量下降更大的患者。
核心结论
- 低术前DLCO与微创肺癌手术后患者报告结局显著下降相关。
- DLCO可能有助于识别术后生活质量下降更大的患者并指导手术决策。
研究设计与样本
- 单中心研究,纳入123例接受胸腔镜肺癌切除术的患者。
- 使用NIH PROMIS工具在术前、术后1个月和6个月进行PRO调查。
- 采用线性混合效应回归模型评估临床变量与PRO评分随时间的关系。
主要发现
- 队列平均年龄67 ± 9.6岁,43%为男性,80%为白人。
- 术前DLCO较低与术后6个月身体功能显著更差相关(P < .01)。
- 术前DLCO较低与术后6个月疼痛强度评分显著更高相关(P < .01)。
- 术后1个月未发现DLCO与PRO评分的显著差异。
- 其他研究的临床因素与PRO评分无显著差异关联。
临床怎么用
- 术前可考虑检测DLCO以识别微创肺癌术后生活质量下降风险较高的患者。
- DLCO结果可能辅助医患沟通和手术决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Patient quality of life (QOL) is a critical outcomes measure in lung cancer surgery. Patient-reported outcomes (PROs) provide valuable insight into the patient experience and allow measurement of preoperative and postoperative QOL. Our objective was to determine which clinical factors predict differences in QOL, as measured by patient-reported physical function and pain intensity among patients undergoing minimally invasive lung cancer surgery. METHODS: PRO surveys assessing physical function and pain intensity were conducted using instruments from the National Institutes of Health Patient-Reported Outcomes Measurement Information System. PRO surveys were administered to patients undergoing minimally invasive lung cancer resections at preoperative, 1-month, and 6-month postoperative time points, in an academic institution. Linear mixed-effects regression models were constructed to assess the association between clinical variables on PRO scores over time. RESULTS: A total of 123 patients underwent a thoracoscopic lung resection for cancer. Mean age of the cohort was 67 ± 9.6 years, 43% were male, and 80% were White. When comparing clinical variables with PRO scores after surgery, lower diffusing capacity of the lungs for carbon monoxide (Dlco) was associated with significantly worse physical function (P < .01) and greater pain intensity scores (P < .01) at 6 months, with no differences identified at 1 month. No other studied clinical factor was associated with significant differences in PRO scores. CONCLUSIONS: Low preoperative Dlco was associated with significant decreases in PRO after minimally invasive lung cancer surgery. Dlco may be of utility in identifying patients who experience greater decline in QOL after surgery and for guiding surgical decision making.
引用
- Khullar OV, Wei JW, Wagh K, et al. Preoperative Lung Function Is Associated With Patient-Reported Outcomes After Lung Cancer Surgery. Ann Thorac Surg. 2020. PMID: 33130117. doi:10.1016/j.athoracsur.2020.09.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。